FGC
CBPO

Financial Gravity Companies’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Financial Gravity Companies’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+2
New +$147 ﹤0.01% 1597
2018
Q1 		$0 Hold
1
– – ﹤0.01% 1784
2017
Q4 		$0 Buy
+1
New +$83 ﹤0.01% 1545

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Financial Gravity Companies's CBPO Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in China Biologic Products Holdings, Inc. (CBPO) in Q4 2018: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1597 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in CBPO as recently as Q1 2018.

Financial Gravity Companies first reported a position in CBPO in Q4 2017 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

  • Financial Gravity Companies held 2 shares of China Biologic Products Holdings, Inc. worth $0 as of Q4 2018.
  • China Biologic Products Holdings, Inc. was a new Financial Gravity Companies position in Q4 2018.
  • China Biologic Products Holdings, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1597 holding.
  • Financial Gravity Companies first reported a position in China Biologic Products Holdings, Inc. in Q4 2017 and has held it in 3 quarters since.
  • 67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.